First Time Loading...

Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX

Watchlist Manager
Ortho Clinical Diagnostics Holdings PLC Logo
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Watchlist
Price: 17.63 USD 0.46% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

OCDX Price Targets Summary
Ortho Clinical Diagnostics Holdings PLC

There are no price targets for OCDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ortho Clinical Diagnostics Holdings PLC Competitors:
Price Targets
TFX
Teleflex Inc
31% Upside
LMAT
LeMaitre Vascular Inc
8% Upside
2216
Broncus Holding Corp
183% Upside
MASI
Masimo Corp
12% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
39% Upside
ABT
Abbott Laboratories
20% Upside
688617
APT Medical Inc
13% Downside
CREO
Creo Medical Group PLC
180% Upside

Revenue
Forecast

Revenue Estimate
Ortho Clinical Diagnostics Holdings PLC

For the last 5 years the compound annual growth rate for Ortho Clinical Diagnostics Holdings PLC's revenue is 4%. The projected CAGR for the next 2 years is 4%.

4%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ortho Clinical Diagnostics Holdings PLC

Operating Income forecast
is not available for
Ortho Clinical Diagnostics Holdings PLC

Net Income
Forecast

Net Income Estimate
Ortho Clinical Diagnostics Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCDX's stock price target?
Not Available

OCDX doesn't have any price targets made by Wall Street professionals.

What is Ortho Clinical Diagnostics Holdings PLC's Revenue forecast?
Projected CAGR
4%

For the last 5 years the compound annual growth rate for Ortho Clinical Diagnostics Holdings PLC's revenue is 4%. The projected CAGR for the next 2 years is 4%.